Increased 30-day mortality in very old ICU patients with COVID-19 compared to patients with respiratory failure without COVID-19.


Journal

Intensive care medicine
ISSN: 1432-1238
Titre abrégé: Intensive Care Med
Pays: United States
ID NLM: 7704851

Informations de publication

Date de publication:
04 2022
Historique:
received: 22 11 2021
accepted: 05 02 2022
pubmed: 27 2 2022
medline: 30 3 2022
entrez: 26 2 2022
Statut: ppublish

Résumé

The number of patients ≥ 80 years admitted into critical care is increasing. Coronavirus disease 2019 (COVID-19) added another challenge for clinical decisions for both admission and limitation of life-sustaining treatments (LLST). We aimed to compare the characteristics and mortality of very old critically ill patients with or without COVID-19 with a focus on LLST. Patients 80 years or older with acute respiratory failure were recruited from the VIP2 and COVIP studies. Baseline patient characteristics, interventions in intensive care unit (ICU) and outcomes (30-day survival) were recorded. COVID patients were matched to non-COVID patients based on the following factors: age (± 2 years), Sequential Organ Failure Assessment (SOFA) score (± 2 points), clinical frailty scale (± 1 point), gender and region on a 1:2 ratio. Specific ICU procedures and LLST were compared between the cohorts by means of cumulative incidence curves taking into account the competing risk of discharge and death. 693 COVID patients were compared to 1393 non-COVID patients. COVID patients were younger, less frail, less severely ill with lower SOFA score, but were treated more often with invasive mechanical ventilation (MV) and had a lower 30-day survival. 404 COVID patients could be matched to 666 non-COVID patients. For COVID patients, withholding and withdrawing of LST were more frequent than for non-COVID and the 30-day survival was almost half compared to non-COVID patients. Very old COVID patients have a different trajectory than non-COVID patients. Whether this finding is due to a decision policy with more active treatment limitation or to an inherent higher risk of death due to COVID-19 is unclear.

Identifiants

pubmed: 35218366
doi: 10.1007/s00134-022-06642-z
pii: 10.1007/s00134-022-06642-z
pmc: PMC8881896
doi:

Banques de données

ClinicalTrials.gov
['NCT03370692', 'NCT04321265']

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

435-447

Subventions

Organisme : Horizon 2020
ID : 831644
Organisme : Medizinische Fakultät, Heinrich-Heine-Universität Düsseldorf
ID : 2020-21

Investigateurs

Philipp Eller (P)
Michael Joannidis (M)
Dieter Mesotten (D)
Pascal Reper (P)
Sandra Oeyen (S)
Walter Swinnen (W)
Helene Brix (H)
Jens Brushoej (J)
Maja Villefrance (M)
Helene Korvenius Nedergaard (HK)
Anders Thais Bjerregaard (AT)
Ida Riise Balleby (IR)
Kasper Andersen (K)
Maria Aagaard Hansen (MA)
Stine Uhrenholt (S)
Helle Bundgaard (H)
Jesper Fjølner (J)
Aliae A R Mohamed Hussein (AARM)
Rehab Salah (R)
Yasmin Khairy Nasr Eldin Mohamed Ali (YKNEM)
Kyrillos Wassim (K)
Yumna A Elgazzar (YA)
Samar Tharwat (S)
Ahmed Y Azzam (AY)
Ayman Abdelmawgoad Habib (AA)
Hazem Maarouf Abosheaishaa (HM)
Mohammed A Azab (MA)
Susannah Leaver (S)
Arnaud Galbois (A)
Tomas Urbina (T)
Cyril Charron (C)
Emmanuel Guerot (E)
Guillaume Besch (G)
Jean-Philippe Rigaud (JP)
Julien Maizel (J)
Michel Djibré (M)
Philippe Burtin (P)
Pierre Garcon (P)
Saad Nseir (S)
Xavier Valette (X)
Nica Alexandru (N)
Nathalie Marin (N)
Marie Vaissiere (M)
Gaëtan Plantefeve (G)
Thierry Vanderlinden (T)
Igor Jurcisin (I)
Buno Megarbane (B)
Anais Caillard (A)
Arnaud Valent (A)
Marc Garnier (M)
Sebastien Besset (S)
Johanna Oziel (J)
Jean-Herlé Raphalen (JH)
Stéphane Dauger (S)
Guillaume Dumas (G)
Bruno Goncalves (B)
Gaël Piton (G)
Eberhard Barth (E)
Ulrich Goebel (U)
Eberhard Barth (E)
Anselm Kunstein (A)
Michael Schuster (M)
Martin Welte (M)
Matthias Lutz (M)
Patrick Meybohm (P)
Stephan Steiner (S)
Tudor Poerner (T)
Hendrik Haake (H)
Stefan Schaller (S)
Stefan Schaller (S)
Stefan Schaller (S)
Detlef Kindgen-Milles (D)
Christian Meyer (C)
Muhammed Kurt (M)
Karl Friedrich Kuhn (KF)
Winfried Randerath (W)
Jakob Wollborn (J)
Zouhir Dindane (Z)
Hans-Joachim Kabitz (HJ)
Ingo Voigt (I)
Gonxhe Shala (G)
Andreas Faltlhauser (A)
Nikoletta Rovina (N)
Zoi Aidoni (Z)
Evangelia Chrisanthopoulou (E)
Antonios Papadogoulas (A)
Mohan Gurjar (M)
Ata Mahmoodpoor (A)
Abdullah Khudhur Ahmed (AK)
Brian Marsh (B)
Ahmed Elsaka (A)
Sigal Sviri (S)
Vittoria Comellini (V)
Ahmed Rabha (A)
Hazem Ahmed (H)
Silvio A Namendys-Silva (SA)
Abdelilah Ghannam (A)
Martijn Groenendijk (M)
Marieke Zegers (M)
Dylan de Lange (D)
Alexander Daniel Cornet (AD)
Mirjam Evers (M)
Lenneke Haas (L)
Tom Dormans (T)
Willem Dieperink (W)
Luis Romundstad (L)
Britt Sjøbø (B)
Finn H Andersen (FH)
Hans Frank Strietzel (HF)
Theresa Olasveengen (T)
Michael Hahn (M)
Miroslaw Czuczwar (M)
Ryszard Gawda (R)
Jakub Klimkiewicz (J)
Maria de Lurdes Campos Santos (MLC)
André Gordinho (A)
Henrique Santos (H)
Rui Assis (R)
Ana Isabel Pinho Oliveira (AIP)
Mohamed Raafat Badawy (MR)
David Perez-Torres (D)
Gemma Gomà (G)
Mercedes Ibarz Villamayor (MI)
Angela Prado Mira (AP)
Patricia Jimeno Cubero (PJ)
Susana Arias Rivera (SA)
Teresa Tomasa (T)
David Iglesias (D)
Eric Mayor Vázquez (EM)
Cesar Aldecoa (C)
Aida Fernández Ferreira (AF)
Begoña Zalba-Etayo (B)
Isabel Canas-Perez (I)
Luis Tamayo-Lomas (L)
Cristina Diaz-Rodriguez (C)
Susana Sancho (S)
Jesús Priego (J)
Enas M Y Abualqumboz (EMY)
Momin Majed Yousuf Hilles (MMY)
Mahmoud Saleh (M)
Nawfel Ben-Hamouda (N)
Andrea Roberti (A)
Alexander Dullenkopf (A)
Yvan Fleury (Y)
Bernardo Bollen Pinto (BB)
Joerg C Schefold (JC)
Mohammed Al-Sadaw (M)

Commentaires et corrections

Type : ErratumIn
Type : CommentIn
Type : CommentIn

Informations de copyright

© 2022. Springer-Verlag GmbH Germany, part of Springer Nature.

Références

Flaatten H, de Lange DW, Artigas A, Bin D, Moreno R, Christensen S et al (2017) The status of intensive care medicine research and a future agenda for very old patients in the ICU. Intensive Care Med 43:1319–1328
doi: 10.1007/s00134-017-4718-z
Nguyen Y-L, Angus DC, Boumendil A, Guidet B (2011) The challenge of admitting the very elderly to intensive care. Ann Intensive Care 1:29
doi: 10.1186/2110-5820-1-29
Stelfox HT, Hemmelgarn BR, Bagshaw SM, Gao S, Doig CJ, Nijssen-Jordan C et al (2012) Intensive Care Unit bed availability and outcomes for hospitalized patients with sudden clinical deterioration. Arch Intern Med 172:467–474
doi: 10.1001/archinternmed.2011.2315
Simchen E, Sprung CL, Galai N, Zitser-Gurevich Y, Bar-Lavi Y, Gurman G et al (2004) Survival of critically ill patients hospitalized in and out of intensive care units under paucity of intensive care unit beds. Crit Care Med 32:1654–1661
doi: 10.1097/01.CCM.0000133021.22188.35
Town JA, Churpek MM, Yuen TC, Huber MT, Kress JP, Edelson DP (2014) Relationship between ICU bed availability, ICU readmission, and cardiac arrest in the general wards. Crit Care Med 42:2037–2041
doi: 10.1097/CCM.0000000000000401
Guidet B, Vallet H, Boddaert J, de Lange DW, Morandi A, Leblanc G, Artigas A, Flaatten H (2018) Caring for the critically ill patients over 80: a narrative review. Ann Intensive Care 8(1):114
doi: 10.1186/s13613-018-0458-7
Dres M, Hajage D, Lebbah S et al (2021) Characteristics, management and prognosis of elderly patients with COVID-19 admitted in the ICU during the first wave. Insights from the Covid-ICU study. Ann Intensive Care 11(1):77
doi: 10.1186/s13613-021-00861-1
Haas LEML (2020) Should we deny ICU admission to the elderly? Ethical considerations in times of COVID-19. Crit Care 24(1):321
doi: 10.1186/s13054-020-03050-x
Clegg A, Young J, Iliffe S, Rikkert MO, Rockwood K (2013) Frailty in elderly people. Lancet 381(9868):752–762. https://doi.org/10.1016/S0140-6736(12)62167-9
doi: 10.1016/S0140-6736(12)62167-9
Rockwood K, Song X, MacKnight C, Bergman H, Hogan DB, McDowell I, Mitnitski A (2005) A global clinical measure of fitness and frailty in elderly people. CMAJ 173(5):489–495
doi: 10.1503/cmaj.050051
Lambden S, Laterre PF, Levy MM, Francois B (2019) The SOFA score-development, utility and challenges of accurate assessment in clinical trials. Crit Care 23(1):374
doi: 10.1186/s13054-019-2663-7
van Heerden PV, Beil M, Guidet B et al (2021) A new multi-national network studying Very old Intensive care Patients (VIPs). Anaesthesiol Intensive Ther 53(4):1–6
Guidet B, de Lange DW, Boumendil A, Leaver S, Watson X, Boulanger C et al (2020) The contribution of frailty, cognition, activity of daily life and comorbidities on outcome in acutely admitted patients over 80 years in European ICUs: the VIP2 study. Intensive Care Med 46:57–69
doi: 10.1007/s00134-019-05853-1
Jung C, Flaatten H, Fjølner J et al (2021) on behalf of the COVIP study group. The impact of frailty on survival in elderly intensive care patients with COVID-19—the COVIP study. Crit Care 25:149
doi: 10.1186/s13054-021-03551-3
Flaatten H et al (2017) The impact of frailty on ICU and 30-day mortality and the level of care in very elderly patients (≥ 80 years). Intensive Care Med 43(12):1820–1828
doi: 10.1007/s00134-017-4940-8
Fronczek J, Polok K, de Lange DW et al (2021) VIP2 study group. Relationship between the Clinical Frailty Scale and short-term mortality in patients ≥ 80 years old acutely admitted to the ICU: a prospective cohort study. Crit Care 25:231
doi: 10.1186/s13054-021-03632-3
Flaatten H, Guidet B, Andersen FH et al (2021) VIP2 Study Group. Reliability of the Clinical Frailty Scale in very elderly ICU patients: a prospective European study. Ann Intensive Care 11(1):22
doi: 10.1186/s13613-021-00815-7
Guidet B, Hodgson E, Feldman C et al (2014) The Durban World Congress Ethics Round Table Conference Report: II. Withholding or withdrawing of treatment in elderly patients admitted to the intensive care unit. J Crit Care 29(6):896–901
doi: 10.1016/j.jcrc.2014.08.004
Depuydt P, Guidet B (2021) Triage policy of severe covid-19 patients: what to do now? Ann Intensive Care. https://doi.org/10.1186/s13613-020-00770-9
doi: 10.1186/s13613-020-00770-9 pubmed: 33502630 pmcid: 7838470
Guidet B, Flaatten H, Leaver S (2021) Age is just a number: how should we triage old patients in the coronavirus disease 2019 pandemic? Eur J Emerg Med 28(2):92–94
doi: 10.1097/MEJ.0000000000000792
Rosenbaum L (2020) Facing Covid-19 in Italy: ethics, logistics, and therapeutics on the epidemic’s front line. N Engl J Med 382:1873–1875
doi: 10.1056/NEJMp2005492
National Institute for Health & Clinical Excellence (NICE) (2021) COVID-19 rapid guideline: managing COVID-NICE guideline [NG191]. https://www.nice.org.uk/guidance/ng191 . Accessed Oct 2021.
Azoulay E, Beloucif S, Guidet B, Pateron D, Vivien B, Le Dorze M (2020) Admission decisions to intensive care units in the context of the major Covid-19 Outbreak: local guidance from the COVID-19 Paris-Region Area. Crit Care 24(1):293
doi: 10.1186/s13054-020-03021-2
Steinberg A, Levy-Lahad E, Karni T, Sprung CL (2020) Israeli position paper: triage decisions for severely ill patients during the COVID-19 pandemic. Chest 158(6):2278–2281
doi: 10.1016/j.chest.2020.07.052
Maves RC, Downar J, Dichter JR et al (2020) ACCP Task Force for Mass Critical Care. Triage of Scarce Critical Care Resources in COVID-19 An Implementation Guide for Regional Allocation: An Expert Panel Report of the Task Force for Mass Critical Care and the American College of Chest Physicians. Chest 158(1):212–225
doi: 10.1016/j.chest.2020.03.063
Dres M, Hajage D, Lebbah S et al (2021) COVID-ICU investigators. Characteristics, management, and prognosis of elderly patients with COVID-19 admitted in the ICU during the first wave: insights from the COVID-ICU study: prognosis of COVID-19 elderly critically ill patients in the ICU. Ann Intensive Care 11(1):77
doi: 10.1186/s13613-021-00861-1
Jung C, Flaatten H, de Lange D, Beil M, Guidet B (2022) The relationship between treatment limitations and pressure on intensive care units in elderly patients. Intensive Care Med 48(1):124–125
doi: 10.1007/s00134-021-06553-5
Guidet B, Flaatten H, Boumendil A et al (2018) Withholding or withdrawing of life-sustaining therapy in older adults (>/= 80 years) admitted to the intensive care unit. Intensive Care Med 44:1027–1038
doi: 10.1007/s00134-018-5196-7
Avidan A, Sprung CL, Schefold JC et al (2021) ETHICUS-2 Study Group. Variations in end-of-life practices in intensive care units worldwide (Ethicus-2): a prospective observational study. Lancet Respir Med 9(10):1101–1110
doi: 10.1016/S2213-2600(21)00261-7
Sprung CL, Ricou B, Hartog CS et al (2019) Changes in end-of-life practices in European Intensive Care Units From 1999 to 2016. JAMA 322(17):1692–1704
doi: 10.1001/jama.2019.14608
Sprung CL, Jennerich AL, Joynt GM et al (2021) The Influence of Geography, Religion, Religiosity and Institutional Factors on Worldwide End-of-Life Care for the Critically Ill: The WELPICUS Study. J Palliat Care 5:8258597211002308. https://doi.org/10.1177/08258597211002308
doi: 10.1177/08258597211002308
Ludwig M, Jacob J, Basedow F, Andersohn F, Walker J (2021) Clinical outcomes and characteristics of patients hospitalized for Influenza or COVID-19 in Germany. Int J Infect Dis 103:316–322
doi: 10.1016/j.ijid.2020.11.204
Hernández Cárdenas C, Lugo G, Hernández García D, Pérez-Padilla R (2021) Comparison of the clinical characteristics and mortality in ARDS due to COVID-19 versus ARDS due to Influenza A-H1N1. MedRxiv. https://doi.org/10.1101/2021.02.07.21251306
doi: 10.1101/2021.02.07.21251306
Auvinen R, Nohynek H, Syrjänen R, Ollgren J, Kerttula T, Mäntylä J, Ikonen N, Loginov R, Haveri A, Kurkela S, Skogberg K (2021) Comparison of the clinical characteristics and outcomes of hospitalized adult COVID-19 and influenza patients—a prospective observational study. Infect Dis (Lond) 53(2):111–121
doi: 10.1080/23744235.2020.1840623
Haniffa R, Beane A, Dongelmans DA et al (2021) Linking of Global Intensive Care Collaboration (LOGIC). Time to revisit treatment limitations in critical care benchmarking. Crit Care Med 49(4):e472–e473
doi: 10.1097/CCM.0000000000004834
Flaatten H, deLange D, Jung C, Beil M, Guidet B (2021) The impact of end-of-life care on ICU outcome. Intensive Care Med 47(5):624–625
doi: 10.1007/s00134-021-06365-7
Flaatten H, Van Heerden V, Jung C, Beil M, Leaver S, Rhodes A, Guidet B, deLange DW (2020) The good, the bad and the ugly: pandemic priority decisions and triage. J Med Ethics. https://doi.org/10.1136/medethics-2020-106489
doi: 10.1136/medethics-2020-106489
Zampieri FG, Bastos LSL, Soares M, Salluh JI, Bozza FA (2021) The association of the COVID-19 pandemic and short-term outcomes of non-COVID-19 critically ill patients: an observational cohort study in Brazilian ICUs. Intensive Care Med 47(12):1440–1449
doi: 10.1007/s00134-021-06528-6

Auteurs

Bertrand Guidet (B)

UPMC Univ Paris 06, INSERM, UMR_S 1136, Institut Pierre Louis d'Epidémiologie et de Santé Publique, Equipe: épidémiologie hospitalière qualité et organisation des soins, Medical Intensive Care, Sorbonne Universités, 184 rue du Faubourg Saint Antoine, 75012, Paris, France. bertrand.guidet@aphp.fr.
Assistance Publique-Hôpitaux de Paris, Hôpital Saint-Antoine, service de réanimation médicale, 75012, Paris, France. bertrand.guidet@aphp.fr.

Christian Jung (C)

Department of Cardiology, Pulmonology and Vascular Medicine, Medical Faculty, Heinrich-Heine-University Duesseldorf, Duesseldorf, Germany.

Hans Flaatten (H)

Department of Clinical Medicine, University of Bergen, Bergen, Norway.
Department of Anaestesia and Intensive Care, Haukeland University Hospital, Bergen, Norway.

Jesper Fjølner (J)

Department of Intensive Care, Aarhus University Hospital, Aarhus, Denmark.

Antonio Artigas (A)

Department of Intensive Care Medicine, CIBER Enfermedades Respiratorias, Corporacion Sanitaria Universitaria Parc Tauli, Autonomous University of Barcelona, Sabadell, Spain.

Bernardo Bollen Pinto (BB)

Department of Acute Medicine, Geneva University Hospitals, Geneva, Switzerland.

Joerg C Schefold (JC)

Department of Intensive Care Medicine, Inselspital, Universitätsspital, University of Bern, Bern, Switzerland.

Michael Beil (M)

Medical Intensive Care, Hadassah Medical Center, Faculty of Medicine, Hebrew University of Jerusalem, Jerusalem, Israel.

Sviri Sigal (S)

Medical Intensive Care, Hadassah Medical Center, Faculty of Medicine, Hebrew University of Jerusalem, Jerusalem, Israel.

Peter Vernon van Heerden (PV)

General Intensive Care, Hadassah Medical Center, Faculty of Medicine, Hebrew University of Jerusalem, Jerusalem, Israel.

Wojciech Szczeklik (W)

Center for Intensive Care and Perioperative Medicine, Jagiellonian University Medical College, Krakow, Poland.

Michael Joannidis (M)

Division of Intensive Care and Emergency Medicine, Department of Internal Medicine, Medical University Innsbruck, Innsbruck, Austria.

Sandra Oeyen (S)

Department of Intensive Care 1K12IC, Ghent University Hospital, Ghent, Belgium.

Eumorfia Kondili (E)

Intensive Care Unit, University Hospital of Heraklion, Medical School University of Crete, Giofirakia, Greece.

Brian Marsh (B)

Mater Misericordiae University Hospital, Dublin, Ireland.

Finn H Andersen (FH)

Department of Anaesthesia and Intensive Care, Ålesund Hospital, Alesund, Norway.
Department of Circulation and Medical Imaging, Norwegian University of Science and Technology, Trondheim, Norway.

Rui Moreno (R)

Centro Hospitalar Universitário de Lisboa Central, Faculdade de Ciências Médicas de Lisboa, Nova Médical School, Unidade de Cuidados Intensivos Neurocríticos e Trauma. Hospital de São José, Lisbon, Portugal.

Maurizio Cecconi (M)

Department of Anaesthesia IRCCS, Instituto Clínico Humanitas, Humanitas University, Milan, Italy.

Susannah Leaver (S)

General Intensive Care, St George's University Hospitals NHS Foundation Trust, London, UK.

Dylan W De Lange (DW)

Department of Intensive Care Medicine, University Medical Center, University Utrecht, Utrecht, the Netherlands.

Ariane Boumendil (A)

UPMC Univ Paris 06, INSERM, UMR_S 1136, Institut Pierre Louis d'Epidémiologie et de Santé Publique, Equipe: épidémiologie hospitalière qualité et organisation des soins, Medical Intensive Care, Sorbonne Universités, 184 rue du Faubourg Saint Antoine, 75012, Paris, France.
Assistance Publique-Hôpitaux de Paris, Hôpital Saint-Antoine, service de réanimation médicale, 75012, Paris, France.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH